Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Smith Julie Diana. Director active across 1 company, notably Meridian Bioscience INC. Aggregated, 5 reports have been recorded. Activity tracked since 16 September 2022. The latest transaction was filed on 6 December 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Smith Julie Diana is a declarant linked to Meridian Bioscience INC, where she holds the role of Sr VP, Controller, PAO. The record shows 5 filings in total, and across the sampled 5 filings the reported volume is EUR 0 for buys and EUR 0 for sells, with filings ranging from 2022-10-05 to 2023-01-31. The dominant transaction nature is Tax withholding.